secwatch.observer — SEC 8-K summary
======================================

Issuer:     Praxis Precision Medicines, Inc. (PRAX)
CIK:        0001689548
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001104659-23-072550
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Praxis Precision Medicines announces $63.3M public offering of common stock and pre-funded warrants at $0.95/share
--------------------------------------------------------------------------------

- Offering includes 55.15M shares of common stock and pre-funded warrants to purchase 7.05M shares at $0.95/$0.9499 per share.
- Underwriters fully exercised option to purchase additional 9.3M shares; net proceeds expected ~$63.3M.
- Proceeds to advance ulixacaltamide Phase 3 for essential tremor and continue PRAX-562, PRAX-222, PRAX-628 epilepsy trials.
- Company expects combined cash and proceeds to fund operations into Q1 2025.
- Closing expected June 21, 2023 subject to customary conditions; pre-funded warrants not listed on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689548/000110465923072550/0001104659-23-072550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689548/000110465923072550/tm238261d5_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer